2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|
Revenue | $4.6B | $4B | $4.5B | $4.6B | $5.8B |
Cost of Revenue | $2.8B | $2.9B | $3.4B | $3.5B | $3.7B |
Gross Profit | $1.8B | $1.2B | $1.1B | $1B | $2.1B |
Gross Profit % | 38% | 29% | 25% | 23% | 36% |
R&D Expenses | $0 | $0 | $0 | $0 | $0 |
2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|
Net Income | $991M | $614M | $233M | -$235M | $1B |
Dep. & Amort. | $581M | $479M | $637M | $681M | $825M |
Def. Tax | $0 | $0 | $0 | $0 | $0 |
Stock Comp. | $16M | $22M | $18M | $15M | $0 |
Chg. in WC | -$246M | $12M | -$206M | -$175M | $0 |
2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|
Cash | $1.3B | $1.2B | $1.1B | $964M | $1.4B |
ST Investments | $0 | $0 | $0 | $0 | $0 |
Cash & ST Inv. | $1.3B | $1.2B | $1.1B | $964M | $1.4B |
Receivables | $56M | $50M | $20M | $25M | $373M |
Inventory | $733M | $703M | $773M | $829M | $1.1B |
AngloGold Ashanti reported a significant improvement in financial performance for FY 2024, with adjusted EBITDA nearly doubling to $2.8 billion and free cash flow increasing almost tenfold to $942 million, driven by disciplined cost management and higher gold prices.
The company announced a revised dividend policy, committing to a base annual minimum of $250 million (or $0.5 per share) and 50% of free cash flow, aiming to align with North American peers and provide more competitive shareholder returns.
Production guidance for 2025 is set at 2.9 to 3.2 million ounces, reflecting an 18% growth at the midpoint, with total cash costs expected to range from $1,125 to $1,225 per ounce, maintaining cost discipline despite inflationary pressures.
Growth capital expenditure is projected to increase in 2025, with key investments including $140 million for deferred stripping at Sukari, $50 million for Nevada operations, and $60 million for the Havana pushback at Tropicana. Nevada's CapEx is expected to rise further to $200-$240 million in 2026.
The company highlighted operational improvements, including successful integration of Sukari, advancements in Obuasi's ramp-up, and continued progress in Nevada projects, while maintaining a strong balance sheet with leverage at 0.2x adjusted net debt to EBITDA.